Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Low Light Dose PDT with Porfimer Sodium for Recurrent Gliomas
NCT00118222Phase 3Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Mar 2005
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of porfimer sodium in malignant glioma (2 arms), sponsored by Case Comprehensive Cancer Center. Primary endpoints: Time to Progression and Overall Survival. Started Mar 2005; status: completed.
02
Drugs
porfimer sodium
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00118222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00118222.